(NASDAQ: HOOK) Hookipa Pharma's forecast annual revenue growth rate of -52.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Hookipa Pharma's revenue in 2024 is $53,552,000.On average, 2 Wall Street analysts forecast HOOK's revenue for 2024 to be $3,742,787,797, with the lowest HOOK revenue forecast at $2,419,330,116, and the highest HOOK revenue forecast at $5,066,245,478. On average, 2 Wall Street analysts forecast HOOK's revenue for 2025 to be $979,606,059, with the lowest HOOK revenue forecast at $781,705,845, and the highest HOOK revenue forecast at $1,177,506,273.
In 2026, HOOK is forecast to generate $1,484,251,605 in revenue, with the lowest revenue forecast at $1,484,251,605 and the highest revenue forecast at $1,484,251,605.